Richard Dubinsky is a Neurology physician affiliated with University of Kansas Medical Center. OpenAlex indexes 96 publications with 7,786 citations (h-index 39).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3901 Rainbow Blvd
4070 Delp Mail Stop 4017
Kansas City, KS 661600001
Telephone
913-588-6970Registry record last updated 8 Jul 2007.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20257 payments
- Boston Scientific CorporationProgram year20251 payment
- ABBVIE INC.Program year202414 payments$18,926openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
86.1%Aromatic Amino Acid Decarboxylation Inhibitor17.6%Carbidopa-Levodopa82%Carbidopa-Levodopa Er13%Rytary5%Part D<11 patientsBenzodiazepine16.4%Clonazepam69%Diazepam9%Lorazepam8%Alprazolam8%Oxazepam6%Part D<11 patients+ 22 more classes in this area
Cardiovascular
7.3%Beta blocker5.6%Propranolol Hcl76%Propranolol Hcl Er24%Part D≥46 patientsCentral alpha-2 Adrenergic Agonist1.5%Clonidine Hcl58%Guanfacine Hcl42%Part D<11 patients+ 1 more class in this area
Musculoskeletal
5.6%gamma-Aminobutyric Acid-ergic Agonist3.4%Baclofen100%Part D≥34 patientsMuscle Relaxant1.3%Cyclobenzaprine Hcl74%Methocarbamol26%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 1990–2009 per NIH RePORTER. The latest:
- CLINICAL TRIAL: MEMANTINE IN HUNTINGTON'S DISEASE
University of Kansas Medical Center
FY2009$3,902M01RR023940
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Mario Castro, MD
University of Kansas Medical Center
Jeffrey Burns, MD
University of Kansas Medical Center
Gary Gronseth, MD
University of Kansas Medical Center
Mazen Dimachkie, MD
University of Kansas Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”